Cargando…
A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer
Improved and cheaper molecular diagnostics allow the shift from “one size fits all” therapies to personalised treatments targeting the individual tumor. However, the wealth of potential targets based on comprehensive sequencing remains a yet unsolved challenge that prevents its routine use in clinic...
Autores principales: | Krentel, Friedemann, Singer, Franziska, Rosano-Gonzalez, María Lourdes, Gibb, Ewan A., Liu, Yang, Davicioni, Elai, Keller, Nicola, Stekhoven, Daniel J., Kruithof-de Julio, Marianna, Seiler, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955125/ https://www.ncbi.nlm.nih.gov/pubmed/33712636 http://dx.doi.org/10.1038/s41598-021-85151-3 |
Ejemplares similares
-
Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
por: Minoli, Martina, et al.
Publicado: (2020) -
Characteristics of upper urinary tract urothelial carcinoma in the context of bladder cancer: a narrative review
por: Giudici, Nicola, et al.
Publicado: (2021) -
American showcase.
Publicado: (1990) -
American showcase
por: Shapiro Ira -
American showcase illustration.
Publicado: (2000)